LSB
Price
$1.33
Change
-$0.00 (-0.00%)
Updated
Apr 24 closing price
Capitalization
25.38M
STTK
Price
$0.84
Change
-$0.01 (-1.18%)
Updated
Apr 24 closing price
Capitalization
40.13M
12 days until earnings call
Ad is loading...

LSB vs STTK

Header iconLSB vs STTK Comparison
Open Charts LSB vs STTKBanner chart's image
LakeShore Biopharma
Price$1.33
Change-$0.00 (-0.00%)
Volume$38.14K
Capitalization25.38M
Shattuck Labs
Price$0.84
Change-$0.01 (-1.18%)
Volume$129.75K
Capitalization40.13M
LSB vs STTK Comparison Chart
Loading...
LSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LSB vs. STTK commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSB is a StrongBuy and STTK is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (LSB: $1.33 vs. STTK: $0.84)
Brand notoriety: LSB and STTK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LSB: 199% vs. STTK: 53%
Market capitalization -- LSB: $25.38M vs. STTK: $40.13M
LSB [@Biotechnology] is valued at $25.38M. STTK’s [@Biotechnology] market capitalization is $40.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LSB’s FA Score shows that 1 FA rating(s) are green whileSTTK’s FA Score has 1 green FA rating(s).

  • LSB’s FA Score: 1 green, 4 red.
  • STTK’s FA Score: 1 green, 4 red.
According to our system of comparison, both LSB and STTK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LSB’s TA Score shows that 3 TA indicator(s) are bullish while STTK’s TA Score has 5 bullish TA indicator(s).

  • LSB’s TA Score: 3 bullish, 7 bearish.
  • STTK’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, STTK is a better buy in the short-term than LSB.

Price Growth

LSB (@Biotechnology) experienced а -3.54% price change this week, while STTK (@Biotechnology) price change was +8.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

STTK is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STTK($40.1M) has a higher market cap than LSB($25.4M). STTK YTD gains are higher at: -30.752 vs. LSB (-61.561). STTK has higher annual earnings (EBITDA): -76.01M vs. LSB (-220.1M). STTK has more cash in the bank: 90.1M vs. LSB (49.5M). STTK has less debt than LSB: STTK (3.62M) vs LSB (369M). LSB has higher revenues than STTK: LSB (672M) vs STTK (6.44M).
LSBSTTKLSB / STTK
Capitalization25.4M40.1M63%
EBITDA-220.1M-76.01M290%
Gain YTD-61.561-30.752200%
P/E RatioN/AN/A-
Revenue672M6.44M10,443%
Total Cash49.5M90.1M55%
Total Debt369M3.62M10,207%
TECHNICAL ANALYSIS
Technical Analysis
LSBSTTK
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
52%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
49%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
41%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
LSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IPEAX5.56N/A
N/A
Voya Large Cap Value Port A
FRSLX22.55N/A
N/A
Nuveen Small/Mid Cap Growth Opp A
JGMRX20.66N/A
N/A
Janus Henderson Triton R
GGUPX8.52N/A
N/A
Goldman Sachs Global Rl Estt Secs P
DWOIX17.15N/A
N/A
BNY Mellon Research Growth I

LSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, LSB has been loosely correlated with STTK. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LSB jumps, then STTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSB
1D Price
Change %
LSB100%
N/A
STTK - LSB
38%
Loosely correlated
-1.57%
GLTO - LSB
32%
Poorly correlated
+3.64%
BCTX - LSB
30%
Poorly correlated
+11.05%
GNFT - LSB
23%
Poorly correlated
+0.78%
IMRX - LSB
22%
Poorly correlated
+3.55%
More

STTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STTK has been loosely correlated with ACAD. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if STTK jumps, then ACAD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STTK
1D Price
Change %
STTK100%
-1.57%
ACAD - STTK
39%
Loosely correlated
+1.44%
LSB - STTK
38%
Loosely correlated
N/A
VRTX - STTK
36%
Loosely correlated
+0.01%
ADCT - STTK
35%
Loosely correlated
+5.43%
NAUT - STTK
34%
Loosely correlated
-3.92%
More